IRL receives SEK 3.8 million from VINNOVA

Today IRL received SEK 3.8 million as development support for the IRL 790 program from VINNOVA (the Swedish Governmental Agency for Innovation Systems) as part of their Forska&Väx funding initiative. This program is directed towards a new, different and innovative treatment for dyskinesisas and psychosis in Parkinsons Disease (PD).

IRL is grateful for this financial support from VINNOVA. This will allow us to more rapidly conclude the required preclinical studies and continue to explore the utility of IRL790 in the treatment in PD, addressing unmet medical needs which are hampering daily life for a large group of patients.

Nicholas Waters, CEO